Relapsed/Progressive Disease and Its Prognostic Factors among Multiple Myeloma Patients Receiving Novel Agent Treatment in North East Peninsular Malaysia: A Single Centre Experience

BACKGROUND: Some multiple myeloma (MM) patients still relapse/progress despite novel agent therapy and relapse/progression in MM is therefore a vital area of ongoing research in the novel treatment era. This retrospective cohort study aimed to evaluate the time to relapse/progression (TTP) among MM...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanafi, Hany Haqimi Wan, Husin, Azlan, Yaacob, Najib Majdi, Abdullah, Abu Dzarr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Penerbit Universiti Sains Malaysia 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605841/
https://www.ncbi.nlm.nih.gov/pubmed/33154703
http://dx.doi.org/10.21315/mjms2020.27.5.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605841/
https://www.ncbi.nlm.nih.gov/pubmed/33154703
http://dx.doi.org/10.21315/mjms2020.27.5.7

Ejemplares similares